Table 1 Demographic characteristics, comorbidity status and outcomes in patients suspected with COVID-19 and SARS-CoV2 PCR-positive hospitalized patients

Overall

3417 (25.5)

2519 (18.9)

5231 (39.3)

2143 (16.1)

–

644 (10)

1402 (21.7)

3573 (55.3)

835 (12.9)

–

Median age, yrs., (IQR)

56 (39)

56 (31)

52 (28)

62 (38)

< 0.001

55 (27)

53 (24)

52 (23)

65 (34)

< 0.001

Mean ± SD, age, yrs

49.66 ± 27.4

53.6 ± 21.82

49.5 ± 21.7

54.3 ± 27.5

< 0.001

54.7 ± 19.3

53.5 ± 16.9

51.1 ± 17.4

58.6 ± 25.1

< 0.001

  < 18 (n = 1690; 12.8%)

634 (18.8)

185 (7.4)

522 (10)

349 (16.4)

< 0.001

23 (3.6)

18 (1.3)

121 (3.4)

84 (10.1)

< 0.001

 18–49 (n = 3721; 28.1%)

776 (23)

781 (31)

1803 (34.6)

361 (16.9)

216 (33.6)

567 (40.4)

1445(40.5)

160 (19.2)

 50–64 (n = 3443; 26%)

737 (21.9)

686 (27.3)

1557 (29.9)

463 (21.7)

206 (32)

444 (31.7)

1215 (34)

166 (19.9)

 65-79 (n = 2908; 22%)

770 (22.9)

588 (23.4)

977 (18.7)

573 (26.9)

125 (19.4)

276 (19.7)

649 (18)

246 (29.5)

  ≥ 80 (n = 1468; 11.1%)

451 (13.4)

276 (11)

353 (6.8)

388 (18.2)

73 (11.4)

97 (6.9)

149 (4.2)

177 (21.2)

 Men

1754 (51.3)

1188 (47.2)

2392 (45.7)

1005 (46.9)

< 0.001

309 (48)

614 (43.8)

1533(42.9)

377 (45.1)

0.097

 Women

1663 (48.7)

1331 (52.8)

2839 (54.3)

1138 (53.1)

335 (52)

788 (56.2)

2040(57.1)

458 (54.9)

 CVD²

824 (24.1)

652 (25.9)

857 (16.4)

635 (29.6)

< 0.001

158 (24.5)

298 (21.3)

484 (13.5)

243 (29.1)

< 0.001

 Diabetics

592 (17.3)

433 (17.2)

751 (14.4)

397 (18.5)

< 0.001

116 (18)

236 (16.8)

520 (14.6)

173 (20.7)

< 0.001

 KD³

137 (4)

72 (2.9)

103 (2)

80 (3.7)

< 0.001

17 (2.6)

33 (2.4)

53 (1.5)

34 (4.1)

< 0.001

 Hypertension

444 (13)

195 (7.7)

372 (7.1)

239 (11.2)

< 0.001

102 (15.8)

101 (7.2)

232 (6.5)

92 (11)

< 0.001

 Malignancies

243 (7.1)

123 (4.9)

160 (3.1)

122 (5.7)

< 0.001

18 (2.8)

29 (2.1)

47 (1.3)

40 (4.8)

< 0.001

 RD⁴

136 (4)

82 (3.3)

100 (1.9)

73 (3.4)

< 0.001

15 (2.3)

49 (3.5)

54 (1.5)

29 (3.5)

< 0.001

 GID⁵

34 (1)

24 (0.95)

31 (0.62)

12 (0.54)

0.061

5 (0.8)

13 (0.9)

11 (0.33)

8 (0.9)

0.005

 BND⁶

230 (6.7)

132 (5.2)

119 (3.4)

160 (7.5)

< 0.001

35 (5.4)

48 (3.4)

84 (2.4)

75 (9)

< 0.001

 BD⁷

23 (0.7)

18 (0.7)

14 (0.3)

13 (0.6)

0.016

2 (0.3)

10 (0.7)

9 (0.3)

3 (0.4)

0.118

 Pregnancy

57 (1.7)

19 (0.8)

73 (1.4)

30 (1.4)

0.024

25 (3)

8 (0.6)

54 (1.5)

25 (3)

0.001

 Others⁸

25 (0.7)

31 (1.2)

29 (0.6)

21 (1)

0.012

3 (0.5)

19 (1.4)

12 (0.4)

11 (1.3)

< 0.001

 No Comorbidities

1570 (45.9)

1219 (48.4)

3346 (64)

967 (45.1)

< 0.001

307 (47.7)

767 (57.7)

2458(68.8)

344 (41.2)

< 0.001

 One

1187 (34.7)

917 (36.4)

1258 (24)

725 (33.8)

222 (34.5)

455 (32.5)

749 (21)

301 (36)

  > = Two

660 (19.3)

383 (15.2)

627 (12)

451 (21)

115 (17.9)

180 (12.8)

366 (10.2)

190 (22.8)

 Length of stay, days, median (IQR)

5 (4)

5 (4)

5 (3)

5 (5)

< 0.001

5 (3)

5 (3)

5 (3)

5 (4)

0.066

 Length of stay, days, Mean ± SD

7.6 ± 9.0

7.5 ± 11.3

7.1 ± 8.6

6.6 ± 6.0

< 0.001

7.03 ± 10.9

6.6 ± 9.4

6.7 ± 7.5

6.3 ± 5.7

0.744

 ICU admission

139 (4.1)

97 (3.9)

176 (3.4)

75 (3.5)

0.344

49 (7.6)

62 (4.4)

138 (3.9)

42 (5)

< 0.001

 In-hospital death

72 (2.1)

167 (6.6)

139 (2.7)

43 (2)

< 0.001

17 (2.6)

95 (6.8)

96 (2.7)

29 (3.5)

< 0.001